The present study investigated the underlying cellular mechanism in the effect of ligustrazine (tetramethylpyrazine, TMP) on the anion secretion of colonic mucosa in rats using a short-circuit current (
Isc) technique in conjunction with “tool drugs.” (i) After a pretreatment of the tissues by bathing the bilateral surface with Cl
−-free Krebs-Henseleit (K-H) solution for over an hour, a basolateral application of 1 mmol/
l TMP produced an increase in
Isc, and the total charges transported for 30 min were about 8.7 ± 1.4 mC/cm
2; an apical pretreatment of DPC and a basolateral addition of acetazolamide decreased the TMP-induced
Isc by about 60% (
P < 0.01) and 45% (
P < 0.05), respectively; a basolateral application of 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS), the inhibitor of Na
+-HCO
3− cotransporter (NBC), did not alter the TMP-induced
Isc. (ii) After the bilateral surface of mucosa was bathed with HCO
3−-free K-H solution for over an hour, a basolateral application of 1 mmol/
l TMP produced an increase in
Isc, and the total charges transported in 30 min were about 8.3 ± 1.9 mC/cm
2; an apical pretreatment of DPC (1 mmol/
l), the inhibitor of Cl
− channels, decreased the TMP-induced
Isc by about 84% (
P < 0.01). The basolateral presence of bumetanide (0.1 mmol/
l), the inhibitor of Na
+-K
+-Cl
− cotransporter (NKCC), significantly reduced the TMP-evoked
Isc by about 86% (
P < 0.01). In conclusion, (i) ligustrazine could promote colonic mucosa secretion Cl
− via apical Cl
− channels and basolateral NKCC; (ii) ligustrazine could promote colonic mucosa secretion HCO
3− via apical Cl
− channels and the basolateral diffusion of CO
2.
View full abstract